Viewing Study NCT05698303


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2025-12-25 @ 5:25 PM
Study NCT ID: NCT05698303
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-01-26
First Post: 2022-12-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: Nanjing IASO Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module